Want to see HK:2607 full AI Analyst Report?

Shanghai Pharmaceuticals Holding Co (2607) Revenue

5 Followers

Shanghai Pharmaceuticals Holding Co Revenue

Shanghai Pharmaceuticals Holding Co had a revenue of 75.48B in the quarter ending Sep 30, 2026, with 4.98%. This bring the company's revenue in the last twelve months to 290.47B, Decreased 0.70%. In the fiscal year ending Dec 31, 2025, Shanghai Pharmaceuticals Holding Co had annual revenue of 283.58B with 3.03% growth.

Revenue (ttm)

290.47B

Revenue Growth

9.12%

P/S Ratio

0.23

Revenue/Employee

HK$5,716,409

Employees

49,608

Market Cap

HK$64.52B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	283.58B	8.33B	+3.03%
Dec 31, 2024	275.25B	14.96B	+5.75%
Mar 31, 2024	260.30B	28.31B	+12.21%
Dec 31, 2022	231.98B	16.16B	+7.49%
Dec 31, 2021	215.82B	23.92B	+12.46%
Dec 31, 2020	191.91B	5.34B	+2.86%
Dec 31, 2019	186.57B	27.48B	+17.27%
Dec 31, 2018	159.08B	28.24B	+21.58%
Dec 31, 2017	130.85B	―	―